Nevro Corp
(NYSE:NVRO)
$
4.58
0.26 (6.02%)
Market Cap: 171.62 Mil
Enterprise Value: 141.17 Mil
PE Ratio: 0
PB Ratio: 0.63
GF Score: 43/100 Nevro Corp at Bank of America Global Healthcare Conference Transcript
May 11, 2023 / 12:00AM GMT
Release Date Price:
$27.11
(-3.01%)
Operator
I'm Travis Steed, Medical Device Analyst at Bank of America. And up next, we have Nevro Corporation. We've got Kevin Thornal, Chief Executive Officer, first time at a conference, so thank you for coming. And got Rod, CFO; and of course, Julie Dewey as well. Thanks for coming. I hope, my mic is on. I'm sure.
Okay. So maybe, Keith, just...
Kevin R. Thornal
Nevro Corp. - President, CEO & Director
Kevin.
Julie D. Dewey
Nevro Corp. - Chief Corporate Communications & IR Officer
I swear.
Travis Lee Steed
BofA Securities, Research Division - MD
The previous CEO was Keith, I see that, sorry. So I was just reading, sorry about that Kevin.
Julie D. Dewey
Nevro Corp. - Chief Corporate Communications & IR Officer
Those of you who know me, it was like that. I said, no, no, no. Here's his name.
Kevin R. Thornal
Nevro Corp. - President, CEO & Director
It's all right.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot